• Rare Disease News
  • [email protected]
Facebook-f Instagram Linkedin-in Pinterest Twitter
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet Our Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Memes
    • Events
    • Patient Worthy FAQs
  • Listen
  • Languages
    • Spanish / Español
    • Russian / русский
    • French / Français
  • Contact
  • Join PW

Daily Archives: October 24, 2022

Home » Archives for October 24, 2022
Study of the Week: Bacteria of the Neisseria Genus Can Worsen Bronchiectasis
source: pixabay.com

Study of the Week: Bacteria of the Neisseria Genus Can Worsen Bronchiectasis

  • Post author:James Moore
  • Post published:October 24, 2022
  • Post category:Bronchiectasis/Bronchiectasis oligospermia

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Bacteria of the Neisseria Genus Can Worsen Bronchiectasis
Scientists Have Created an Atlas Connecting Fungi to Thirty-Five Cancers
source: unsplash.com

Scientists Have Created an Atlas Connecting Fungi to Thirty-Five Cancers

  • Post author:Rose Duesterwald
  • Post published:October 24, 2022
  • Post category:Cancer

  A team of researchers at Israel’s Weizmann Science Institute and California University in San Diego linked fungi to approximately 35 cancers. They created a pan-cancer mycobiome atlas exposing new…

Continue Reading Scientists Have Created an Atlas Connecting Fungi to Thirty-Five Cancers
Vegzelma Approved for Six Cancer Types
source: shutterstock.com

Vegzelma Approved for Six Cancer Types

  • Post author:Jessica Lynn
  • Post published:October 24, 2022
  • Post category:Cervical Cancer/Colorectal cancer/Renal Cell Carcinoma

  In late September 2022, Healio reported that the U.S. Food and Drug Administration (FDA) approved bevacizumab-adcd (Vegzelma), a biosimilar of Genentech’s bevacizumab (Avastin). The approval of biosimilars such as…

Continue Reading Vegzelma Approved for Six Cancer Types
ICYMI: Flooding Linked to Cholera Deaths in Yobe State
qimono / Pixabay

ICYMI: Flooding Linked to Cholera Deaths in Yobe State

  • Post author:Jessica Lynn
  • Post published:October 24, 2022
  • Post category:Cholera

  Each year, an estimated 2.9 million cases of cholera are reported across the globe. Caused by Vibrio cholerae (V. cholerae) bacteria, cholera can cause shock, dehydration, and even death.…

Continue Reading ICYMI: Flooding Linked to Cholera Deaths in Yobe State
Children with Bell’s Palsy May Recover Without Treatment, Study Shares
Source: pixabay.com

Children with Bell’s Palsy May Recover Without Treatment, Study Shares

  • Post author:Jessica Lynn
  • Post published:October 24, 2022
  • Post category:Bell's Palsy

  Oral corticosteroid drugs can help treat Bell’s palsy, a condition which causes temporary facial weakness or paralysis, if the muscles remain paralyzed over time. According to News Medical, researchers…

Continue Reading Children with Bell’s Palsy May Recover Without Treatment, Study Shares

OF INTEREST


XLH Image


X-Linked Hypophosphatemia: Unnderstanding this Hereditary, Progressive, and Lifelong Condition


podcast setup on a desk


Catalyst’s LEMS Aware Podcast Helps Connect Patients

Patient Stories

STUDY OF THE WEEK

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

READ MORE

RARE CLASSROOM

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most mysterious diseases and conditions. This series is an opportunity to learn the basics about some of the diseases that almost no one hears much about.

READ MORE
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Policy
Privacy Policy for CA Residents
EU Privacy Notice

© Copyright Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info